Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | C2CD5 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of C2CD5 mRNA | CTD | PMID:22079256 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of C2CD5 mRNA | CTD | PMID:33387578 | 4-hydroxyphenyl retinamide | decreases expression | EXP | | 6480464 | Fenretinide results in decreased expression of C2CD5 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of C2CD5 mRNA | CTD | PMID:30047161 | acetamide | increases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of C2CD5 mRNA | CTD | PMID:31881176 | all-trans-retinoic acid | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of C2CD5 mRNA | CTD | PMID:33167477 | amitrole | increases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of C2CD5 mRNA | CTD | PMID:30047161 | antimycin A | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Antimycin A results in decreased expression of C2CD5 mRNA | CTD | PMID:33512557 | aristolochic acid A | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of C2CD5 mRNA | CTD | PMID:33212167 | atrazine | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of C2CD5 mRNA | CTD | PMID:22378314 | atrazine | affects methylation | ISO | C2cd5 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of C2CD5 gene | CTD | PMID:28931070 | azoxystrobin | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | azoxystrobin results in decreased expression of C2CD5 mRNA | CTD | PMID:33512557 | benzo[a]pyrene | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of C2CD5 mRNA | CTD | PMID:20064835 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of C2CD5 intron | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | Benzo(a)pyrene results in increased expression of C2CD5 mRNA | CTD | PMID:21839799 | bisphenol A | decreases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of C2CD5 mRNA | CTD | PMID:25181051 more ... | caffeine | increases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | Caffeine results in increased expression of C2CD5 mRNA | CTD | PMID:20864626 | caffeine | affects phosphorylation | ISO | C2CD5 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of C2CD5 protein | CTD | PMID:35688186 | cobalt dichloride | decreases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | cobaltous chloride results in decreased expression of C2CD5 mRNA | CTD | PMID:24386269 | copper(II) sulfate | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of C2CD5 mRNA | CTD | PMID:19549813 | coumarin | increases phosphorylation | ISO | C2CD5 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of C2CD5 protein | CTD | PMID:35688186 | cyclosporin A | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of C2CD5 mRNA | CTD | PMID:20106945 and PMID:25562108 | deguelin | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | deguelin results in decreased expression of C2CD5 mRNA | CTD | PMID:33512557 | dicrotophos | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of C2CD5 mRNA | CTD | PMID:28302478 | elemental selenium | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Selenium results in decreased expression of C2CD5 mRNA | CTD | PMID:19244175 | epoxiconazole | increases expression | EXP | | 6480464 | epoxiconazole results in increased expression of C2CD5 mRNA | CTD | PMID:35436446 | fenpyroximate | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | fenpyroximate results in decreased expression of C2CD5 mRNA | CTD | PMID:33512557 | flutamide | decreases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of C2CD5 mRNA | CTD | PMID:24793618 | FR900359 | affects phosphorylation | ISO | C2CD5 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of C2CD5 protein | CTD | PMID:37730182 | genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of C2CD5 mRNA | CTD | PMID:32186404 | hydrogen peroxide | affects expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of C2CD5 mRNA | CTD | PMID:20044591 | hydrogen peroxide | multiple interactions | ISO | C2CD5 (Homo sapiens) | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of C2CD5 protein | CTD | PMID:18951874 | leflunomide | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of C2CD5 mRNA | CTD | PMID:28988120 | maneb | multiple interactions | EXP | | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of C2CD5 mRNA | CTD | PMID:36117858 | menadione | affects expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of C2CD5 mRNA | CTD | PMID:20044591 | methoxyacetic acid | increases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | methoxyacetic acid results in increased expression of C2CD5 mRNA | CTD | PMID:20864626 | methylmercury chloride | increases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | methylmercuric chloride results in increased expression of C2CD5 mRNA | CTD | PMID:20864626 | Monobutylphthalate | increases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | monobutyl phthalate results in increased expression of C2CD5 mRNA | CTD | PMID:20864626 | nickel atom | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Nickel results in decreased expression of C2CD5 mRNA | CTD | PMID:23195993 | oxaliplatin | multiple interactions | ISO | C2cd5 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of C2CD5 mRNA | CTD | PMID:25729387 | paracetamol | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of C2CD5 mRNA | CTD | PMID:21420995 and PMID:29067470 | paracetamol | decreases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of C2CD5 mRNA | CTD | PMID:33387578 | paraquat | multiple interactions | EXP | | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of C2CD5 mRNA | CTD | PMID:36117858 | picoxystrobin | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | picoxystrobin results in decreased expression of C2CD5 mRNA | CTD | PMID:33512557 | potassium chromate | multiple interactions | ISO | C2CD5 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of C2CD5 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of C2CD5 mRNA | CTD | PMID:22079256 | pyrimidifen | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | pyrimidifen results in decreased expression of C2CD5 mRNA | CTD | PMID:33512557 | quercetin | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of C2CD5 mRNA | CTD | PMID:21632981 | quercetin | increases phosphorylation | ISO | C2CD5 (Homo sapiens) | 6480464 | Quercetin results in increased phosphorylation of C2CD5 protein | CTD | PMID:35688186 | selenium atom | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Selenium results in decreased expression of C2CD5 mRNA | CTD | PMID:19244175 | silicon dioxide | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Silicon Dioxide results in decreased expression of C2CD5 mRNA | CTD | PMID:25351596 | sulfadimethoxine | increases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of C2CD5 mRNA | CTD | PMID:30047161 | tebufenpyrad | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of C2CD5 mRNA | CTD | PMID:33512557 | theophylline | multiple interactions | ISO | C2CD5 (Homo sapiens) | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of C2CD5 protein | CTD | PMID:18951874 | thifluzamide | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | thifluzamide results in decreased expression of C2CD5 mRNA | CTD | PMID:33512557 | toluene | increases expression | ISO | C2cd5 (Rattus norvegicus) | 6480464 | Toluene results in increased expression of C2CD5 mRNA | CTD | PMID:22967744 | topotecan | multiple interactions | ISO | C2cd5 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of C2CD5 mRNA | CTD | PMID:25729387 | triptonide | decreases expression | EXP | | 6480464 | triptonide results in decreased expression of C2CD5 mRNA | CTD | PMID:33045310 | trovafloxacin | decreases expression | EXP | | 6480464 | trovafloxacin results in decreased expression of C2CD5 mRNA | CTD | PMID:35537566 | valproic acid | decreases methylation | ISO | C2CD5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of C2CD5 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | C2CD5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of C2CD5 mRNA | CTD | PMID:23179753 | valproic acid | affects splicing | ISO | C2cd5 (Rattus norvegicus) | 6480464 | Valproic Acid affects the splicing of C2CD5 mRNA | CTD | PMID:29427782 | |